About this page
Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.
How to read it
- Form 4
- The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
- Buy (P) and Sell (S)
- Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
- Value
- Shares times price, as reported on the filing.
- 10b5-1
- A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
- Late filing
- A Form 4 filed more than two business days after the trade.
- Vs. S&P 500
- How the stock did after the trade minus how the overall market did in the same weeks.
A real example
In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.
Explain it like I'm 13
If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.
Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.
Heartflow, Inc. (HTFL): Insider Trades and Fund Holdings
In the past 12 months, Heartflow, Inc. insiders reported no open-market purchases and 21 sales worth $17.7M; 21 of the sales were reported as made under a 10b5-1 trading plan.
Timeline: news and trades
Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.
- Oct 22, 2026Insider saleChief Medical Officer Campbell Rogers sold $1.3 million under a 10b5-1 plan
- Oct 22, 2026Planned saleRogers Campbell (officer) filed notice to sell about $1.3 million around Oct 22, 2026
- Oct 22, 2026Planned saleRogers Campbell (member of immediate family of any of the foregoing) filed notice to sell about $311,027 around Oct 22, 2026
- Oct 13, 2026Planned saleFarquhar John C.M. (officer, director) filed notice to sell about $1.9 million around Oct 12, 2026
- Oct 12, 2026Insider saleCEO John C.m. Farquhar sold $1.9 million under a 10b5-1 plan
- Sep 18, 2026Insider saleChief Medical Officer Campbell Rogers sold $987,052 under a 10b5-1 plan
- Sep 18, 2026Insider saleCFO Vikram Verghese sold $850,926 under a 10b5-1 plan
- Sep 18, 2026Planned saleRogers Campbell (officer) filed notice to sell about $987,052 around Sep 18, 2026
- Sep 18, 2026Planned saleVerghese Vikram (officer) filed notice to sell about $850,927 around Sep 18, 2026
- Sep 18, 2026Planned saleRogers Campbell (member of immediate family of any of the foregoing) filed notice to sell about $283,498 around Sep 18, 2026
- Sep 17, 2026Insider saleCFO Vikram Verghese sold $379,816 under a 10b5-1 plan
- Sep 17, 2026Planned saleVerghese Vikram (officer) filed notice to sell about $379,815 around Sep 17, 2026
- Sep 15, 2026Insider saleCFO Vikram Verghese sold $33,408 under a 10b5-1 plan
- Sep 15, 2026Planned saleVerghese Vikram (officer) filed notice to sell about $33,408 around Sep 15, 2026
- Sep 14, 2026Insider saleCFO Vikram Verghese sold $230,744 under a 10b5-1 plan
- Sep 14, 2026Planned saleVerghese Vikram (officer) filed notice to sell about $230,744 around Sep 14, 2026
- Sep 11, 2026Insider saleCFO Vikram Verghese sold $1.5 million under a 10b5-1 plan
- Sep 11, 2026Insider saleCEO John C.m. Farquhar sold $194,500 under a 10b5-1 plan
- Sep 11, 2026Planned saleVerghese Vikram (officer) filed notice to sell about $1.5 million around Sep 11, 2026
- Sep 11, 2026Planned saleFarquhar John C.M. (officer, director) filed notice to sell about $194,500 around Sep 11, 2026
- Sep 10, 2026Insider saleCEO John C.m. Farquhar sold $1.6 million under a 10b5-1 plan
- Sep 10, 2026Planned saleFarquhar John C.M. (officer, director) filed notice to sell about $1.6 million around Sep 10, 2026
- Sep 8, 2026Insider saleCFO Vikram Verghese sold $332,212 under a 10b5-1 plan
- Sep 8, 2026Planned saleVerghese Vikram (officer) filed notice to sell about $332,212 around Sep 8, 2026
- Sep 3, 2026Insider saleCFO Vikram Verghese sold $1.4 million under a 10b5-1 plan
- Sep 3, 2026Planned saleVerghese Vikram (officer) filed notice to sell about $1.4 million around Sep 3, 2026
- Sep 2, 2026Insider saleCFO Vikram Verghese sold $297,326 under a 10b5-1 plan
- Sep 2, 2026Planned saleVerghese Vikram (officer) filed notice to sell about $297,326 around Sep 2, 2026
- Aug 21, 2026Insider saleCEO John C.m. Farquhar sold $1.4 million under a 10b5-1 plan
- Aug 21, 2026Planned saleFarquhar John C.M. (officer, director) filed notice to sell about $1.4 million around Aug 21, 2026
- Aug 18, 2026Insider saleCEO John C.m. Farquhar sold $1.5 million under a 10b5-1 plan
- Aug 18, 2026Planned saleFarquhar John C.M. (officer, director) filed notice to sell about $1.5 million around Aug 18, 2026
- Aug 17, 2026Insider saleChief Medical Officer Campbell Rogers sold $380,099 under a 10b5-1 plan
- Aug 17, 2026Planned saleRogers Campbell (officer) filed notice to sell about $380,099 around Aug 17, 2026
- Aug 14, 2026Insider saleCEO John C.m. Farquhar sold $607,774 under a 10b5-1 plan
- Aug 10, 2026Insider saleCEO John C.m. Farquhar sold $638,730 under a 10b5-1 plan
- Jul 15, 2026Insider saleChief Medical Officer Campbell Rogers sold $237,113 under a 10b5-1 plan
- Jul 10, 2026Insider saleCEO John C.m. Farquhar sold $626,096 under a 10b5-1 plan
- Jun 30, 2026FundRenaissance Technologies opened a position in Q2 2026 (13F filed Aug 13, 2026)
- Jun 24, 2026Insider saleCEO John C.m. Farquhar sold $1.4 million under a 10b5-1 plan
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 26, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 26 | Campbell RogersChief Medical Officer | ▼ SELL10b5-1 | $1.32M |
| Oct 14 | John C.m. FarquharCEO | ▼ SELL10b5-1 | $1.93M |
| Sep 21 | Campbell RogersChief Medical Officer | ▼ SELL10b5-1 | $987K |
| Sep 18 | Vikram VergheseCFO | ▼ SELL10b5-1 | $851K |
| Sep 18 | Vikram VergheseCFO | ▼ SELL10b5-1 | $380K |
| Sep 15 | Vikram VergheseCFO | ▼ SELL10b5-1 | $1.49M |
| Sep 15 | Vikram VergheseCFO | ▼ SELL10b5-1 | $231K |
| Sep 15 | Vikram VergheseCFO | ▼ SELL10b5-1 | $33K |
| Sep 14 | John C.m. FarquharCEO | ▼ SELL10b5-1 | $1.63M |
| Sep 14 | John C.m. FarquharCEO | ▼ SELL10b5-1 | $195K |
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Campbell Rogers | Chief Medical Officer | 0 | $0 | 4 | $2.92M |
| John C.m. Farquhar | CEO | 0 | $0 | 9 | $9.81M |
| Vikram Verghese | CFO | 0 | $0 | 8 | $4.98M |
Buybacks and executive pay
Heartflow, Inc. spent $228,000 buying back its own shares in 2023.
From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.
A All 21 insider trades reported on time. How it is graded
Tracked funds that report HTFL
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 382,700 | $11.2M | ▲ New |
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →